Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 3, 2016 (10 years ago)

PredniSONE Tablets USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

PredniSONE Tablets USP, 1 mg, 100-count bottles, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-4741-25.

Affected NDC 0054-4741-25

Compare with the code on your package — it is the most precise check available.

Drug: Prednisone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
PredniSONE
NDC 00054-4741
1 mg/1 Tablet
Oral
Hikma Pharmaceuticals USA Inc. Rx
Recalling firm
West-Ward Pharmaceutical
NDC code
0054-4741-25
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0008-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Prednisone recalls

See all
Class II · Moderate risk

PredniSONE Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0193-2024
Class II · Moderate risk

Prednisone Tablets

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Terminated Labeling / mix-up Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020
Class III · Low risk

Prednisone 20 mg

Labeling: Not elsewhere classified. NDC number is incorrect on the container.

Terminated Labeling / mix-up Northwind Pharmaceuticals LLC NDC 51655-320-53 D-0485-2016
Class II · Moderate risk

Prednisone active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-858-2015

Other recalls by West-Ward Pharmaceutical

All 2016 recalls
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Terminated Impurity / degradation West-Ward Pharmaceutical Corp. NDC 0641-6028-25 D-1139-2015
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing.

Terminated Impurity / degradation West-Ward Pharmaceutical Corporation NDC 0641-6028-25 D-0420-2015
Class II · Moderate risk

Isoniazid Tablets

Failed Dissolution Specifications: Stability lots cannot support dissolution past the 36 month time point.

Terminated Dissolution failure West-Ward Pharmaceutical Corp. NDC 0143-1261-01 D-1414-2014